In parallel, the signal transducer and activator of transcription 3 (STAT3) signaling pathway has been implicated in the emergence of drug resistance in CML due to its regulatory influence on various cellular processes, including proliferation, survival, and metabolism (10, 11). This evidence concerns the gene STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive.